About 3B Blackbio Biotech India Limited
Data last updated:
3B Blackbio Biotech India Limited was a private limited company based in Bhopal, Madhya Pradesh, India, operated as a subsidiary of Kilpest India Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the biotechnology segment of the life sciences sector. It was incorporated on 12 November 2010.
The company was registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2010PTC024717. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹1.03 Cr. It was led by directors including Shabbar Husain and Nikhil Kuber Dubey.
Its last annual general meeting (AGM) was held on 25 August 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 7 C Industrial Area Govindpura, Bhopal, Madhya Pradesh, India – 462023.
As per the financials filed for FY 2023, the company reported a revenue of ₹55.39 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹26.51 Cr (net margin 47.9%) and EBITDA of ₹35.94 Cr (EBITDA margin 64.9%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years and 46% over five years.
The company was associated with 1 brand: 3B BlackBio Biotech. As per MCA filings, the company had satisfied charges of ₹82.25 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹4.1 Cr; the latest was in June 2019. Its 3 peer companies in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is JC Biotech Private Limited with revenue of ₹60.12 Cr. The company has 2 MSME Form 1 returns on record between 2019 and 2020, listing 6 overdue payments to 6 micro and small suppliers.
The last known website on record is 3bblackbio.com.
Company details
Contact details
3B Blackbio Biotech India Limited's registered office is in Bhopal, Madhya Pradesh. Its website is 3bblackbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address7 C Industrial Area Govindpura, Bhopal, Madhya Pradesh, India – 462023
- IndustryLife Sciences, Biotechnology
To see the full contact details of 3B Blackbio Biotech India Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
3B Blackbio Biotech India operates one associated brand: 3B BlackBio Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality PCR-based molecular diagnostic kits. | 3bblackbio.com |
Business activity
The main business activity of 3B Blackbio Biotech India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of 3B Blackbio Biotech India Limited, buy the company report.
Financials of 3B Blackbio Biotech India Limited
FY 2023 filings available3B Blackbio Biotech India Limited reported revenue of ₹55.39 Cr (down 25% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 46%. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹55.39 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.94 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26.51 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 64.9% | ||||
| Net Profit Margin | 47.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of 3B Blackbio Biotech India Limited, buy the company report.
Board of directors of 3B Blackbio Biotech India Limited
3B Blackbio Biotech India has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shabbar Husain | Director | 01 Oct 2019 | 7 Years 0 Months | As last reported |
| Nikhil Kuber Dubey Also directs: 3B Blackbio DX Limited, Mithala Laboratoreis Pvt Ltd | Director | 12 Nov 2010 | 15 Years 11 Months | As last reported |
| Dhirendra Dubey Also directs: 3B Blackbio DX Limited | Director | 12 Nov 2010 | 15 Years 11 Months | As last reported |
Peer comparison
3B Blackbio Biotech India Limited is compared with the 3 companies closest to it by revenue in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| JC Biotech Private Limited | ₹60.12 Cr (FY 2025) | -4.0% | Hyderabad, Telangana, India | |||
| Biofusion Therapeutics Limited | ₹56.53 Cr (FY 2023) | 41.0% | Bengaluru, Karnataka, India | |||
| 3B Blackbio Biotech India Limitedthis company | ₹55.39 Cr (FY 2023) | ₹26.51 Cr | 47.9% | -25.0% | Bhopal, Madhya Pradesh, India | |
| Chemtek Scientific Private Limited | ₹52.2 Cr (FY 2025) | 10.0% | Thane, Maharashtra, India |
To see the full peer comparison of 3B Blackbio Biotech India Limited, buy the company report.
Auditor
3B Blackbio Biotech India Limited is audited by R. C. BAHETI AND COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. C. BAHETI AND COMPANY | FY 2023 | 21400993AAAADV3550 |
Shareholding
The shareholding of 3B Blackbio Biotech India Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of 3B Blackbio Biotech India Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Oct 2016 | 100055312 | State Bank of India | ₹7.25 Lakh | Satisfied | |
| 27 Jun 2011 | 10295334 | State Bank of India | ₹75 Lakh | Satisfied |
To see the full charge records of 3B Blackbio Biotech India Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
3B Blackbio Biotech India Limited has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹4.1 Cr; the latest was in June 2019.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2019 | Funding round | ₹4 Cr | Investors: Kilpest India Limited, 3 individuals |
| Mar 2017 | Rights issue | ₹42.8 Lakh | Investors: Kilpest India Limited |
| Apr 2014 | Secondary share transfer | Undisclosed | Buyer: Kilpest India Limited Seller: an individual |
| Apr 2014 | Funding round | ₹10 Lakh | Investors: Kilpest India Limited |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: Kilpest India Limited Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
3B Blackbio Biotech India Limited has 2 court cases on record: 2 filed by 3B Blackbio Biotech India. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Indore | Interim or miscellaneous application | Filed by the company | Disposed |
| NCLT, Indore | Court case (C.P.(CAA)) | Filed by the company | Disposed |
To see the full case history of 3B Blackbio Biotech India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
3B Blackbio Biotech India Limited has 2 MSME Form 1 returns on record between 2019 and 2020, listing 6 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Aristogene Biosciences Private Limited | |||
| A'niche Infotech Solutions Private Limited | |||
| an individual supplier |
To see the full MSME payment records of 3B Blackbio Biotech India Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
3B Blackbio Biotech India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of 3B Blackbio Biotech India Limited, buy the company report.
Recent activity
3B Blackbio Biotech India Limited has 5 board changes on record since 2010: 3 appointments and 2 cessations. The latest: Shabbar Husain was appointed as Director on 01 Oct 2019.
1 earlier event is in the company report.
Frequently asked questions
3B Blackbio Biotech India has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
3B Blackbio Biotech India was a private limited company based in Bhopal, Madhya Pradesh, India. The company worked in biotechnology, within the life sciences industry. It was incorporated on 12 November 2010 and is registered under CIN U24232MP2010PTC024717. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
3B Blackbio Biotech India was incorporated on 12 November 2010. It is registered with the Registrar of Companies, Gwalior.
3B Blackbio Biotech India had 3 directors:
- Shabbar Husain - Director
- Nikhil Kuber Dubey - Director
- Dhirendra Dubey - Director
The CIN (Corporate Identification Number) of 3B Blackbio Biotech India is U24232MP2010PTC024717. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of 3B Blackbio Biotech India is at 7 C Industrial Area Govindpura, Bhopal, Madhya Pradesh, India – 462023.
3B Blackbio Biotech India can be reached through the website 3bblackbio.com. Its registered office is in Bhopal, Madhya Pradesh, India.
The latest financial statements of 3B Blackbio Biotech India on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 25 August 2023. Year-wise statements from 2015 are in the company report.
No. 3B Blackbio Biotech India has 1 GST registration on record and it is cancelled or inactive.
3B Blackbio Biotech India operated in the life sciences industry, in the biotechnology segment.
3B Blackbio Biotech India has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹4.1 Cr; the latest was in June 2019.
The peers of 3B Blackbio Biotech India by revenue are JC Biotech Private Limited, Biofusion Therapeutics Limited, Chemtek Scientific Private Limited, all in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).